Prof. Lin Zhang is an Assistant Professor in the Department of Anaesthesia and Intensive Care at The Chinese University of Hong Kong (CUHK), where she also serves as Lead Scientist of the Microbiota I-Center (MagIC), and Principal Investigator at the Li Ka Shing Institute of Health Sciences. Her research bridges basic biology and translational medicine, with a keen focus on host–microbe crosstalk and the establishment of the microbiome in early life. Through the landmark MOMMY cohort study, Prof. Zhang and team has demonstrated that early microbial blueprints can either protect against or predispose individuals to chronic diseases, opening new avenues for early-life intervention. She has authored over 150 publications, including nearly 100 original research articles in leading journals such as Nature Medicine, Cell Host & Microbe, Nature Microbiology, and Gut. Prof. Zhang serves on the editorial board of iMeta and a reviewer for grant agencies (e.g. NSFC, ANZCA, AGA Abstract Review Committee). Her contributions have been recognised with the NSFC-RGC Joint Research Scheme award (2025/26), the CUHK Young Researcher Award (2024), Global Grants for Gut Health Abstract Award (IHMC 2026), and a Silver Medal at the International Exhibition of Inventions in Geneva (2025). She has been named a Top 2% Scientist in Clinical Medicine for three consecutive years (2023–2025).
